JB CHEMICALS & PHARMACEUTICALS
|
JB CHEMICALS & PHARMACEUTICALS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 52.97 | 49.86 | 57.96 | 35.20 | 24.11 |
| CEPS(Rs) | 67.77 | 59.35 | 66.92 | 43.83 | 31.11 |
| DPS(Rs) | 17.75 | 16.50 | 16.50 | 11.00 | 5.00 |
| Book NAV/Share(Rs) | 304.83 | 268.04 | 234.17 | 185.75 | 184.47 |
| Tax Rate(%) | 26.16 | 23.54 | 24.86 | 21.93 | 32.41 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 21.28 | 21.81 | 27.23 | 21.28 | 18.61 |
| EBIT Margin(%) | 18.09 | 20.50 | 29.58 | 19.84 | 17.75 |
| Pre Tax Margin(%) | 16.98 | 20.29 | 29.22 | 19.66 | 17.47 |
| PAT Margin (%) | 12.54 | 15.51 | 21.96 | 15.35 | 11.80 |
| Cash Profit Margin (%) | 16.04 | 18.44 | 25.32 | 19.09 | 15.19 |
| Performance Ratios | |||||
| ROA(%) | 11.44 | 13.69 | 19.55 | 12.53 | 8.52 |
| ROE(%) | 18.51 | 19.89 | 27.64 | 18.69 | 13.28 |
| ROCE(%) | 22.79 | 25.48 | 36.53 | 23.71 | 19.59 |
| Asset Turnover(x) | 0.91 | 0.88 | 0.89 | 0.82 | 0.72 |
| Sales/Fixed Asset(x) | 1.46 | 1.63 | 1.73 | 1.57 | 1.54 |
| Working Capital/Sales(x) | 3.36 | 2.86 | 1.69 | 2.34 | 2.04 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.69 | 0.61 | 0.58 | 0.64 | 0.65 |
| Receivable days | 63.16 | 69.29 | 65.62 | 67.22 | 67.63 |
| Inventory Days | 46.91 | 55.55 | 55.59 | 53.31 | 50.81 |
| Payable days | 72.35 | 89.07 | 92.33 | 82.55 | 69.69 |
| Valuation Parameters | |||||
| PER(x) | 37.21 | 31.59 | 21.63 | 14.44 | 14.91 |
| PCE(x) | 29.08 | 26.54 | 18.73 | 11.60 | 11.56 |
| Price/Book(x) | 6.47 | 5.88 | 5.35 | 2.74 | 1.95 |
| Yield(%) | 0.90 | 1.05 | 1.32 | 2.16 | 1.39 |
| EV/Net Sales(x) | 4.99 | 5.01 | 4.74 | 2.21 | 1.75 |
| EV/Core EBITDA(x) | 22.28 | 20.84 | 14.40 | 9.17 | 8.28 |
| EV/EBIT(x) | 26.59 | 23.81 | 16.04 | 11.15 | 9.86 |
| EV/CE(x) | 3.84 | 3.96 | 3.77 | 1.95 | 1.23 |
| M Cap / Sales | 4.84 | 5.02 | 4.74 | 2.21 | 1.76 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 29.91 | 18.69 | 15.09 | 8.00 | 16.23 |
| Core EBITDA Growth(%) | 21.11 | -13.39 | 57.02 | 23.38 | 36.50 |
| EBIT Growth(%) | 15.93 | -15.58 | 71.55 | 20.75 | 47.71 |
| PAT Growth(%) | 6.21 | -13.93 | 64.66 | 40.43 | 39.83 |
| EPS Growth(%) | 6.22 | -13.98 | 64.66 | 45.99 | 45.66 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.23 | 0.01 | 0.02 | 0.02 | 0.02 |
| Current Ratio(x) | 2.56 | 2.91 | 2.76 | 2.47 | 2.03 |
| Quick Ratio(x) | 1.87 | 2.01 | 2.25 | 1.94 | 1.72 |
| Interest Cover(x) | 16.40 | 99.60 | 83.43 | 108.09 | 62.74 |
| Total Debt/Mcap(x) | 0.04 | - | - | 0.01 | 0.01 |
Compare Financial Ratios of peers of JB CHEMICALS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JB CHEMICALS & PHARMACEUTICALS | ₹29,276.9 Cr | 4.4% | 15.7% | 82% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹364,315.0 Cr | 1.1% | -6.6% | 56.7% | Stock Analytics | |
| CIPLA | ₹114,614.0 Cr | 0.2% | -4.4% | 54.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹105,233.0 Cr | 4.8% | 18.9% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,900.0 Cr | 4.3% | 2.6% | 29.9% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,426.0 Cr | 2.2% | -4.6% | 86.6% | Stock Analytics | |
JB CHEMICALS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JB CHEMICALS & PHARMACEUTICALS | 4.4% |
15.7% |
82% |
| SENSEX | 1% |
2.2% |
23.7% |
You may also like the below Video Courses
